Tech Company Financing Transactions
Benevir Funding Round
Benevir, operating out of Gaithersburg, raised $2 million from private investors.
Transaction Overview
Company Name
Announced On
11/17/2017
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd. 150
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
The BeneVir oncolytic virus platform is based on T-StealthTM technology, which overcomes a major barrier to the clinical success of oncolytic viruses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Mulvey
Chief Scientific Officer
Ian Mohr
Founder
Katherine Sacksteder
VP - R & D
Steven Fuhrmann
Browse more venture capital transactions:
Prev: 11/17/2017: Inboard venture capital transaction
Next: 11/18/2017: Axios venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs